X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/lipidor-updates-on-phase-iii-study-of-akp02-in-treatment-of-psoriasis--half-of-patients-now-recruited-301551868.html
https://www.prnewswire.com/news-releases/lipidor-expands-clinical-program-announces-investment-in-new-drug-development-project-against-acne-vulgaris-301447211.html
https://www.prnewswire.com/news-releases/lipidor-submits-new-patent-application-and-expands-collaboration-with-cannassure-using-lipidors-akvano-technology-for-medicinal-cannabis-products-301411934.html
https://www.prnewswire.com/news-releases/lipidor-announces-approval-to-start-phase-iii-clinical-study-of-drug-candidate-akp02-for-treatment-of-psoriasis-301385432.html
https://www.prnewswire.com/news-releases/lipidor-ab-licence-agreement-grants-menarini-group-company-relife-srl-exclusive-rights-to-register-promote-distribute-and-market-two-new-psoriasis-drug-candidates-for-potential-value-of-meur-70-301324729.html
https://www.prnewswire.com/news-releases/lipidor--update-on-the-companys-phase-iii-clinical-trial-of-drug-candidate-akp02-for-treatment-of-psoriasis-301274602.html
https://www.prnewswire.com/news-releases/lipidor-and-cannassure-enter-exclusive-licensing-agreement-regarding-topical-medical-cannabis-products-based-on-lipidors-akvano-technology-301209902.html
https://www.prnewswire.com/news-releases/lipidor-signs-cooperation-agreement-with-contract-manufacturer-to-offer-licensees-the-opportunity-for-gmp-production-301193781.html
https://www.prnewswire.com/news-releases/lipidor-signs-agreement-with-cro-for-implementation-of-phase-iii-clinical-study-of-drug-candidate-akp-02-against-psoriasis-301089831.html
https://www.prnewswire.com/news-releases/lipidor-signs-agreement-with-cro-for-implementation-of-phase-iii-clinical-study-of-drug-candidate-akp-02-against-psoriasis-301089831.html
Market Place
Share 
